Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1989;64:398-406

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, M.
Right arrow Articles by Singal, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, M.
Right arrow Articles by Singal, P. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OXYGEN

Circulation Research, Vol 64, 398-406, Copyright © 1989 by American Heart Association


ARTICLES

Higher antioxidative capacity during a chronic stable heart hypertrophy

M Gupta and PK Singal
Cardiovascular Sciences Division, St. Boniface General Hospital Research Center, Winnipeg, Canada.

Changes in oxygen radical mechanisms during 6-48 weeks of heart hypertrophy in rats subjected to a narrowing of the subdiaphragmatic aorta were examined. During this period, hypertrophied hearts demonstrated a stable hyperfunction, as indicated by an elevated but stable left ventricular systolic pressure, dP/dt, and aortic pressure and no change in left ventricular end diastolic pressure. Experimental animals showed increased heart-to-body weight ratios; however, the conventional signs of heart failure such as increased wet-to-dry weight ratios of liver and lung, ascites, or pleural effusion were absent. Hearts were examined for superoxide dismutase, glutathione peroxidase, and lipid peroxide activities. The superoxide dismutase activity was significantly higher in hypertrophied hearts at 6 and 12 weeks as compared with sham-operated rats (sham controls), while no difference was seen at 24 and 48 weeks due to a marked increase in the superoxide dismutase activity of sham control hearts in these age groups. During the period studied, glutathione peroxidase activity remained unchanged in controls but was significantly elevated in hypertrophied hearts. Lipid peroxide activity as indicated by the malondialdehyde content was significantly lower in hypertrophied hearts. Perfusion of isolated control and hypertrophy hearts with xanthine-xanthine oxidase, an exogenous source of oxygen radicals, resulted in contractile failure and rise in resting tension. In hypertrophied hearts, however, the contractile force was better maintained and there was a lesser rise in resting tension after exposure to xanthine-xanthine oxidase. The study suggests the development of a higher antioxidative capacity during the stable phase of hypertrophy due to a chronic pressure overload.


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S. E. Purdom-Dickinson, E. V. Sheveleva, H. Sun, and Q. M. Chen
Translational Control of Nrf2 Protein in Activation of Antioxidant Response by Oxidants
Mol. Pharmacol., October 1, 2007; 72(4): 1074 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Buscemi, C. Murray, A. Doherty-Kirby, G. Lajoie, M. A. Sussman, and J. E. Van Eyk
Myocardial subproteomic analysis of a constitutively active Rac1-expressing transgenic mouse with lethal myocardial hypertrophy
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2325 - H2333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Benderdour, G. Charron, B. Comte, R. Ayoub, D. Beaudry, S. Foisy, D. deBlois, and C. Des Rosiers
Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2122 - H2131.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Conti, I. M. Renaud, B. Poirier, O. Michel, M.-F. Belair, C. Mandet, P. Bruneval, I. Myara, and J. Chevalier
High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R793 - R800.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Takahashi, K. Okumura, H. Matsui, Y. Saburi, H. Kamiya, K. Matsubara, T. Asai, M. Ito, and T. Murohara
Impact of {alpha}-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol
Cardiovasc Res, June 1, 2003; 58(3): 565 - 574.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M.-o Date, T. Morita, N. Yamashita, K. Nishida, O. Yamaguchi, Y. Higuchi, S. Hirotani, Y. Matsumura, M. Hori, M. Tada, et al.
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 907 - 912.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. MacCarthy, D. J. Grieve, J.-M. Li, C. Dunster, F. J. Kelly, and A. M. Shah
Impaired Endothelial Regulation of Ventricular Relaxation in Cardiac Hypertrophy: Role of Reactive Oxygen Species and NADPH Oxidase
Circulation, December 11, 2001; 104(24): 2967 - 2974.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Khaper and P. K. Singal
Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1461 - 1466.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Dieterich, U. Bieligk, K. Beulich, G. Hasenfuss, and J. Prestle
Gene Expression of Antioxidative Enzymes in the Human Heart : Increased Expression of Catalase in the End-Stage Failing Heart
Circulation, January 4, 2000; 101(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. K. Seneviratne, T. Li, N. Khaper, and P. K. Singal
Effects of methionine on endogenous antioxidants in the heart
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2124 - H2128.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. P. Palace, M. F. Hill, F. Farahmand, and P. K. Singal
Mobilization of Antioxidant Vitamin Pools and Hemodynamic Function After Myocardial Infarction
Circulation, January 12, 1999; 99(1): 121 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. M. Freeman, D. J. Brown, and J. E. Rush
Antioxidant Status in Dogs with Idiopathic Dilated Cardiomyopathy
J. Nutr., December 1, 1998; 128(12): 2768S - 2768.
[Full Text]


Home page
Cardiovasc ResHome page
P. K Singal, N. Khaper, V. Palace, and D. Kumar
The role of oxidative stress in the genesis of heart disease
Cardiovasc Res, December 1, 1998; 40(3): 426 - 432.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Hwang, A. A. Dempsey, R.-X. Wang, M. Rezvani, J. D. Barrans, J. D. MHSc, K.-S. Dai, H.-Y. Wang, H. Ma, E. Cukerman, et al.
A Genome-Based Resource for Molecular Cardiovascular Medicine : Toward a Compendium of Cardiovascular Genes
Circulation, December 16, 1997; 96(12): 4146 - 4203.
[Abstract] [Full Text]


Home page
CirculationHome page
M. F. Hill and P. K. Singal
Right and Left Myocardial Antioxidant Responses During Heart Failure Subsequent to Myocardial Infarction
Circulation, October 7, 1997; 96(7): 2414 - 2420.
[Abstract] [Full Text]